OR WAIT null SECS
October 11, 2017
BARDA has entered a $12-million contract with biopharmaceutical firm Achaogen for the late-stage development of an antibiotic against resistant bacteria, and as a potential treatment for biowarfare agents.
Johnson & Johnson’s Janssen Sciences Ireland UC will invest more than EUR 300 million (US$355 million) to expand manufacturing capacity for biologic medicines at its Ireland facility.
October 02, 2017
Sartorius begins building a new, EUR 30-million (US$35.2 million) Cell Culture Technology Center in Ulm, Germany.
September 26, 2017
ADC Bio announces plans to expand into clinical and commercial drug manufacturing for ADCs.
September 02, 2017
Modeling tools help process engineers optimize a biopharmaceutical facility’s capacity.
September 01, 2017
Innovative new technologies released over the past several months seek to enhance bio/pharmaceutical development and manufacturing.
July 18, 2017
The addition of 20,000 sq. ft. of manufacturing and office space increases Avecia’s Milford, Ma, oligonucleotide capacity to 3.0 mol.
July 05, 2017
A Supreme Court decision and improvements in analytical processes may speed the biosimilar approval process.
June 14, 2017
Sartorius Stedim Biotech combined the company’s ambr 15 bioreactor system with the Nova BioProfile FLEX2 cell culture analyzer for laboratory experiments.
May 30, 2017
BioVectra will open its new microbial fermentation and complex chemistry site, including the capability to handle high-potency APIs, by the end of 2017.